siRNA-Based Approach for Castration-Resistant Prostate Cancer Therapy Targeting Androgen Receptor Signaling Pathway - Supplementary material
收藏DataCite Commons2024-05-15 更新2025-04-15 收录
下载链接：
https://tandf.figshare.com/articles/dataset/siRNA-Based_Approach_for_Castration-Resistant_Prostate_Cancer_Therapy_Targeting_Androgen_Receptor_Signaling_Pathway_-_Supplementary_material/24297763/1
下载链接
链接失效反馈官方服务：
资源简介：
<b>Supplementary Table 1. </b>The major characteristics of CSPC and CRPC. CSPC, Castration-Sensitive Prostate Cancer; CRPC, Castration-Resistant Prostate Cancer.<b>Supplementary</b><b> T</b><b>able 2</b>. Interventional clinical trials of siRNA use for cancer. Search criteria: Cancer, siRNA. (Accessed in December 2022, sorted from the newest to the oldest start dates). U.S., United States; U.K., United Kingdom.<br>
**补充表1**：去势敏感性前列腺癌（Castration-Sensitive Prostate Cancer，CSPC）与去势抵抗性前列腺癌（Castration-Resistant Prostate Cancer，CRPC）的主要特征。
**补充表2**：小干扰RNA（small interfering RNA，siRNA）用于癌症的介入性临床试验。检索标准：癌症、siRNA。（检索于2022年12月，按研究起始日期由新至旧排序）。美国（U.S.，United States）；英国（U.K.，United Kingdom）。
提供机构：
Taylor & Francis
创建时间：
2023-10-12
